Synthis Therapeutics, Inc.

Home | Synthistx

New York, United States · Founded 2018 · $579K raised

Headquarters
New York, New York
Employees
1–10
Founded
2018
Business Model
B2B
Total Funding
$579K
Last Round
$579K GrantJan 2024
Rounds
2

About

Synthis Therapeutics is a New York-based immuno-oncology biotech developing first-in-class anti-fibrotic antibody drug conjugates (ADCs) that selectively inhibit TGF-β in disease-driving cells. Its lead candidates SYN101 and SYN303 target cancer, IPF, myelofibrosis, and fibrotic diseases. The company has received SBIR awards from NHLBI and NCI and has been granted NYC lab space multiple times.

Summary

Synthis Therapeutics, Inc. is a Biotech company based in New York, United States, founded in 2018. It has raised $579K in total across 2 rounds, most recently a $579K Grant round in Jan 2024. Investors include National Institutes of Health.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantJan 2024
$579K

Sign up to see all 2 rounds

Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Synthis Therapeutics, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/synthis-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/synthis-therapeutics-inc" alt="Synthis Therapeutics, Inc. on Indexed.vc" width="260" height="76" /></a>